• Gestational Polystyrene Nano-Plastics Impair Male Fertility

  2026-05-23

  This study establishes a mechanistic link between gestational polystyrene nano-plastics (PS-NPs) exposure and adult male offspring reproductive dysfunction, utilizing multi-omics approaches to construct a partial adverse outcome pathway. The findings highlight disrupted testicular structure and function, emphasizing the need for mechanistic assays to dissect environmental contaminant toxicity.

• HATU in Peptide Synthesis Chemistry: Advanced Workflows & Ti

  2026-05-22

  HATU accelerates high-yield amide and ester formation in peptide synthesis, outperforming legacy coupling reagents for both routine and challenging targets. This guide delivers actionable protocols, optimization strategies, and troubleshooting insights to unlock the reagent’s full potential in modern research.

• SU 5402 Applications: Advancing Kinase Inhibition in Cancer

  2026-05-22

  SU 5402 enables precise modulation of receptor tyrosine kinase signaling, empowering advanced workflows in cancer and neuronal research. This article delivers actionable protocols, troubleshooting strategies, and a translation of recent stem cell–based virology advances to optimize your kinase inhibition assays.

• Leupeptin Hemisulfate Salt: Advanced Strategies for Protease

  2026-05-21

  Explore the unique mechanisms and cutting-edge applications of Leupeptin hemisulfate salt for precision protease activity regulation. This article offers a scientifically deep perspective, integrating assay innovation with practical guidance for advanced protein degradation and viral inhibition research.

• Bazedoxifene: Translational Leverage for Osteoporosis and Be

  2026-05-21

  Explore the mechanistic depth and translational potential of Bazedoxifene, a third-generation SERM, in enhancing bone mineral density and advancing research in postmenopausal osteoporosis, while uncovering its emerging cross-domain antimalarial activity. This article uniquely bridges validated estrogen receptor modulation with strategic opportunities for drug repurposing, offering protocol guidance and critical analysis for translational researchers.

• 2-Hydroxypropyl-β-cyclodextrin: Technical Solubility Guide

  2026-05-20

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of solubilizing poorly water-soluble, hydrophobic compounds—particularly those with aromatic or phenyl groups. Its validated uses are as a solubility enhancer or drug formulation excipient in pharmaceutical and biochemical research; applications outside these contexts are not supported by current product documentation.

• Gepotidacin (GSK2140944): Mechanisms, Validation, and Strate

  2026-05-20

  This thought-leadership article explores the mechanistic and translational landscape of Gepotidacin (GSK2140944), a novel triazaacenaphthylene antibiotic from APExBIO. It details its unique inhibition of bacterial DNA gyrase and topoisomerase IV, reviews experimental validation and protocol parameters, evaluates its clinical and competitive positioning against resistant pathogens, and provides actionable guidance for translational researchers seeking to harness this agent in antibiotic resistance research and drug discovery.

• Chloroquine and Everolimus Induce Apoptosis in Melanoma Cell

  2026-05-19

  This study demonstrates that co-treatment with chloroquine and everolimus activates apoptosis and alters lipid distribution in melanoma cells. The integration of mTOR inhibition with autophagy blockade offers mechanistic insights into cancer cell death, with implications for rational drug combination strategies.

• BODIPY 581/591 C11: Redefining Lipid Peroxidation Assays in

  2026-05-19

  Discover how BODIPY 581/591 C11, a leading ratiometric fluorescent probe, transforms lipid peroxidation detection in endothelial ferroptosis research and diabetic osteoporosis. This article offers advanced assay guidance and unique insight into integrating this probe for translational bone health studies.

• Macrophage Polarization and TLR4 Pathway in Colitis-Associat

  2026-05-18

  Liu et al. investigated how Jiedu Xiaozheng Yin (JXY), a traditional Chinese medicine, inhibits colitis-associated colorectal cancer (CAC) by promoting macrophage polarization towards the anti-tumorigenic M1 phenotype via the TLR4 signaling pathway. Their findings offer new mechanistic insight into immune modulation for CAC treatment and highlight the relevance of AP-1 pathway inhibition in tumor microenvironment research.

• Methoxy-X04: Illuminating Amyloid Beta Clearance Mechanisms

  2026-05-18

  Explore how Methoxy-X04, a fluorescent amyloid beta probe, redefines Alzheimer's disease research by enabling real-time visualization of plaque clearance dynamics in vivo. This deep-dive article uniquely bridges probe chemistry, microglial biology, and translational assay design.

• Dacarbazine: Applied Workflows for Antineoplastic Chemothera

  2026-05-17

  Dacarbazine stands out as a versatile antineoplastic chemotherapy drug, offering robust DNA-damaging action in the treatment of malignant melanoma, Hodgkin lymphoma, and sarcoma. This article details bench-ready experimental workflows, troubleshooting strategies, and evidence-driven optimizations for maximizing Dacarbazine’s efficacy in translational research.

• Pseudo-UTP in mRNA Synthesis: Precision Modulation for Thera

  2026-05-16

  Explore how pseudo-modified uridine triphosphate (Pseudo-UTP) empowers precision mRNA synthesis, enhances stability, and reduces immunogenicity. This article uniquely analyzes mechanistic data and protocol implications, building on the latest research and practical insights for advanced RNA therapeutics.

• Mutant p53 Reactivation via Small Molecule-Induced Proximity

  2026-05-15

  This study introduces TRAP-1, a small molecule that restores transcriptional activity to the p53Y220C mutant by inducing a ternary complex with BRD4. The approach demonstrates a mechanistically novel strategy for reactivating tumor suppressor functions in cancer cells, with implications for targeted therapy design.

• Lycopene Counteracts DON-Induced Gut Barrier Dysfunction via

  2026-05-15

  This study demonstrates that lycopene can mitigate intestinal barrier impairment and suppress NLRP3 inflammasome activation induced by deoxynivalenol (DON) in IPEC-J2 cells, primarily by targeting the ERK signaling pathway. These findings suggest a molecular basis for lycopene's protective role against mycotoxin-mediated enterotoxicity and highlight methodological best practices for immunofluorescence-based detection of pathway activation.

449 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page